These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8225504)

  • 61. Human biomonitoring and the 32P-postlabeling assay.
    Beach AC; Gupta RC
    Carcinogenesis; 1992 Jul; 13(7):1053-74. PubMed ID: 1638670
    [No Abstract]   [Full Text] [Related]  

  • 62. [Risk of occupational cancers. Effect of deoxyribonucleic acid adducts].
    Deschamps F; Pfohl-Leszkowicz A; Trenque T
    Presse Med; 1994 Jun; 23(21):991-4. PubMed ID: 7937648
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins.
    Schut HA; Shiverick KT
    FASEB J; 1992 Aug; 6(11):2942-51. PubMed ID: 1644258
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 32P-postlabelling analysis of alkylphosphotriesters in DNA.
    Saris CP; Damman SJ; van den Ende AM; Westra JG; den Engelse L
    IARC Sci Publ; 1993; (124):127-32. PubMed ID: 8225475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Evaluating work intensity in major and auxiliary occupations of by-product coke industry].
    Smagulov NK; Alpysbayeva ZhT
    Med Tr Prom Ekol; 2015; (3):26-9. PubMed ID: 26036020
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The implications for risk assessment of measuring the relative contribution to exposure from occupation, environment and lifestyle: hemoglobin adducts from amino- and nitro-arenes.
    Neumann HG; van Dorp C; Zwirner-Baier I
    Toxicol Lett; 1995 Dec; 82-83():771-8. PubMed ID: 8597141
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris.
    Al Zabadi H; Ferrari L; Laurent AM; Tiberguent A; Paris C; Zmirou-Navier D
    BMC Cancer; 2008 Mar; 8():67. PubMed ID: 18325085
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Biomonitoring usage to evaluate character and severity of exposure to chemical factor].
    Med Tr Prom Ekol; 2010; (12):28-33. PubMed ID: 21442937
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [New perspectives in monitoring of exposures to carcinogens].
    Pavanello S; Lotti M
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):88-91. PubMed ID: 23393809
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a strategy for biological monitoring in a chemical plant producing 3,3'-dichlorobenzidine dihydrochloride.
    Knoell KF; Will N; Leng G; Selinski S; Hengstler JG; Golka K; Bolt HM
    J Toxicol Environ Health A; 2012; 75(8-10):551-6. PubMed ID: 22686315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 32P-postlabelling of DNA adducts in white blood cells of foundry workers.
    Savela K; Leppälä S; Hemminki K
    Arch Toxicol Suppl; 1989; 13():101-3. PubMed ID: 2774915
    [No Abstract]   [Full Text] [Related]  

  • 72. Is it possible to use biomonitoring for the quantitative assessment of formaldehyde occupational exposure?
    Chiarella P; Tranfo G; Pigini D; Carbonari D
    Biomark Med; 2016 Dec; 10(12):1287-1303. PubMed ID: 27924628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biomonitoring at the UK Health and Safety Laboratory.
    Cocker J; Jones K; Morton J; Mason HJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):383-6. PubMed ID: 17321210
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methods for detecting DNA damaging agents in humans. Summary: adducts.
    Lohman PH
    IARC Sci Publ; 1988; (89):13-22. PubMed ID: 3198196
    [No Abstract]   [Full Text] [Related]  

  • 75. Exposure and effect monitoring: a critical appraisal of their practical application.
    Aitio A; Kallio A
    Toxicol Lett; 1999 Sep; 108(2-3):137-47. PubMed ID: 10511255
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Symposium on the significance of low level exposures to DNA adduct inducing chemicals, Department of Health, London, UK, May 1996.
    Mulholland C; Battershill J; Fielder RJ
    Mutagenesis; 1997 Jul; 12(4):305-12. PubMed ID: 9237778
    [No Abstract]   [Full Text] [Related]  

  • 77. Postlabelling methods--an historical review.
    Randerath K; Randerath E
    IARC Sci Publ; 1993; (124):3-9. PubMed ID: 7693586
    [No Abstract]   [Full Text] [Related]  

  • 78. Use of 32P-postlabelling to distinguish between genotoxic and nongenotoxic carcinogens.
    Phillips DH
    IARC Sci Publ; 1992; (116):211-24. PubMed ID: 1428082
    [No Abstract]   [Full Text] [Related]  

  • 79. Methods for detecting DNA damaging agents in humans. Summary: epidemiological applications.
    Hogstedt LC
    IARC Sci Publ; 1988; (89):21-2. PubMed ID: 3198201
    [No Abstract]   [Full Text] [Related]  

  • 80. Analytical tools and biomonitoring for carcinogens in complex mixtures.
    O'Neill IK
    IARC Sci Publ; 1990; (104):123-33. PubMed ID: 2228110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.